Excerpts

In the IMspire150 study, triple therapy showed a significantly better PFS in patients with elevated LDH as well as a numerical trend towards better outcomes in patients with a high tumor mutational burden [ 30 ].

Likewise, even if only showing a strong trend for formal statistical significance, the ECOG-PS 2 patients undergoing IO-based treatments exhibited a poorer survival (12.1 (95% CI, 3.9–20.4) months vs.

Similarly, the patients with a poorer PS receiving IO-based treatments had a numerically shorter median PFS while showing a significant trend for statistical significance (6.1 (95% CI, 0.6–11.5) months vs.

Despite the inclusion of various prognostic factors in the multivariable model, the impact of annual caseload on the outcomes remained highly significant.

At first interim analysis of OS conducted at 45.3 months of median follow-up, IMpower010 showed a trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population (HR 0.71, 95% CI 0.49–1.03) but not in the all randomized stage II-IIIA (HR 0.95, 95% CI 0.74–1.24) or intent-to-treat population (HR 0.995, 95% CI 0.78–1.28).

On the other hand, the cumulative incidence of infectious keratitis in the NPC group revealed a significant trend of increment compared to that in the non-NPC group.

Infectious mononucleosis was significantly associated with an increased incidence of tumors of the hematopoietic and lymphoid tissues (IRR: 1.75; 95% CI: 1.22–2.50) and showed a strong trend towards an association with prostate cancer (IRR: 3.09; 95% CI: 1.23–7.76).

In multivariable regression models, infectious mononucleosis showed a trend towards a higher incidence of cancer in general in the age group > 50 years (incidence rate ratio (IRR): 1.32; 95% CI: 1.04–1.67) and among men (IRR: 1.36; 95% CI: 1.07–1.72).

Although the prevalence of ESCC is always high, recent years have witnessed an increasing trend of EAC in the United States of America (USA) and other Western countries [ 6 , 7 ].

A larger difference was apparent after 96 h, when the numbers in the unsorted sample rose to about 17.8%, whereas the numbers in the CD34 − OV-6 − sample only rose to 10.5% on average. 3.3.

Again, we should caution that the basal Y118 signal in LNCaP cell was very weak to begin with, and that the decrease in signal quantitated on the right ( Figure 3 C, left panel), despite its annotation as moderately significant, should be considered in the context of whether a “weak signal” becoming “negligible” can be taken as a possible indication of biological significance for motility.

Their data included all populations with or without treatment, and the difference was apparent among BDC locations.

The FTO protein expression was markedly significant in all the PC cells screed when compared to the normal HPDE cells.

For the FABP inhibitors, a weak trend towards greater inhibitory effects with increased number of FABP targets was observed in the cell growth and FA uptake assays (cf.

Thus, risk factors for breast cancer have been identified that may be significant. 5.

Compared to HCW, the NAb levels were significantly (ANOVA) lower in all cohorts, except WM off-therapy (G2) and showed a trend for MM off-therapy cohort (G5), with both showing a ~80–90% response rate.

Kaplan–Meier curves showed a positive trend for tumor size < 5 cm and PFS (0.068).

In the samples from the two groups in which the high dose rate SIBs were administered early in the radiotherapy schedule, highly significant differences are seen between each of the three irradiation schedules (low dose rate only, MBI SIB + low dose rate and PBI SIB plus low dose rate). 4.

Interestingly, the neoadjuvant chemotherapy subgroup showed a trend of improved survival in favor of HIPEC (61.8 vs. 48.2, p -value 0.4; 17.4 vs. 15.4 months, p -value 0.04).

However, a meta-analysis comprising six observational studies reported an overall risk as marginally insignificant (adjusted OR 0.89, 95% CI 0.79–1.01) [ 13 ].

EAC has shown an increasing trend and is now the predominant type of EC in the USA and other Western countries [ 3 ].

Even though a direct clinical comparison with the aforementioned results from photon radiotherapy is not possible due to different patient cohorts, a clear trend toward improved organ sparing by proton therapy can be derived.

In general, prostate tissues from mice in the same treatment group demonstrated an expected trend compared to control mice, however, with noticeable heterogeneity, particularly with respect to p-Akt/Akt in mice in the Gnetin 35 -Diet group ( Figure 4 A, right ) ( Supplementary Figure S1 ).

Conclusions SMART for liver metastases has highly significant dosimetric benefits with increased PTV coverage and reduced maximum doses in OAR.

Although an increasing trend has been observed in the use of an ICG fluorescence-guided system for hepatoblastoma (HB) surgery, studies involving a larger cohort of children is still lacking, which indicates a limitation in the application of ICG for pediatric HB surgery.